0000000001314772

AUTHOR

Miriam Lohr

showing 3 related works from this author

Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer

2014

Claudins (CLDNs) are central components of tight junctions that regulate epithelial-cell barrier function and polarity. Altered CLDN expression patterns have been demonstrated in numerous cancer types and lineage-specific CLDNs have been proposed as therapy targets. The objective of this study was to assess which fraction of patients with non-small-cell lung cancer (NSCLC) express CLDN6 and CLDN18 isoform 2 (CLDN18.2). Protein expression of CLDN6 and CLDN18.2 was examined by immunohistochemistry on a tissue microarray (n=355) and transcript levels were supportively determined based on gene expression microarray data from fresh-frozen NSCLC tissues (n=196). Both were analyzed with regard to …

Gene isoformCancer ResearchPathologymedicine.medical_specialtyTissue microarrayCancerBiologymedicine.diseaseGene expression profilingOncologymedicineCancer researchAdenocarcinomaImmunohistochemistryClaudinLung cancerInternational Journal of Cancer
researchProduct

Loss of circadian clock gene expression is associated with tumor progression in breast cancer

2014

Several studies suggest a link between circadian rhythm disturbances and tumorigenesis. However, the association between circadian clock genes and prognosis in breast cancer has not been systematically studied. Therefore, we examined the expression of 17 clock components in tumors from 766 node-negative breast cancer patients that were untreated in both neoadjuvant and adjuvant settings. In addition, their association with metastasis-free survival (MFS) and correlation to clinicopathological parameters were investigated. Aiming to estimate functionality of the clockwork, we studied clock gene expression relationships by correlation analysis. Higher expression of several clock genes (e.g., C…

Circadian clockCLOCK ProteinsBreast Neoplasmstumor progressionBiologyBioinformaticsbreast cancerBreast cancerCircadian Clockscircadian clockclock genesmedicineHumansCLOCK Proteinsskin and connective tissue diseasesMolecular BiologyNPAS2metastasis-free survivalCell Biologymedicine.diseaseCLOCKPER2Cancer researchFemaleReportsestrogen receptorDevelopmental BiologyARNTL2PER1Cell Cycle
researchProduct

Loss of circadian clock gene expression is associated with tumor progression in breast cancer

2015

Several studies suggest a link between circadian rhythm disturbances and tumorigenesis. However, the association between circadian clock genes and prognosis in breast cancer has not been systematically studied. Therefore, we examined the expression of 17 clock components in tumors from 766 node-negative breast cancer patients that were untreated in both neoadjuvant and adjuvant settings. In addition, their association with metastasis-free survival (MFS) and correlation to clinicopathological parameters were investigated. Aiming to estimate functionality of the clockwork, we studied clock gene expression relationships by correlation analysis. Higher expression of several clock genes (e.g., C…

skin and connective tissue diseases
researchProduct